Summit Therapeutics Inc (SMMT)
NASDAQ · Biotechnology
Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.
Price history
Daily closes and volumeAI Analysis Generated from the indicator readings below. Educational only.
Summit Therapeutics Inc is trading at $17.27, up 3.07% on the session. The 50 day average sits at $15.03 and the 200 day at $16.36, which puts the stock in a downtrend. RSI is at 54.5, which reads as neutral, and MACD is bearish crossover. Volume is below average.
The nearest support is around $15.18 with resistance near $18.42, so that band frames the current range. Average daily movement is roughly $1.12, or about 6.5% of the share price, which is what any stop placement has to allow for. The overall health score of 58 out of 100 combines a trend score of 67, momentum of 54 and a risk score of 50.